SEC Form 4 · accession 0001127602-16-052315
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Praveen Tyle
Officer — EVP, R&D
Period of report
May 16, 2016
Accepted (ET)
May 16, 2016 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.24 | May 16, 2016 | A | 100,000 | A | — | May 16, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (5/16/2017) and vests 1/48th per month for each month of service thereafter.